Literature DB >> 9920850

Normal T-cell telomerase activity and upregulation in human immunodeficiency virus-1 infection.

K C Wolthers1, S A Otto, G B Wisman, S Fleury, P Reiss, R W ten Kate, A G van der Zee, F Miedema.   

Abstract

In human immunodeficiency virus (HIV)-1 infection, decrease of telomere length is mainly found in CD8(+) T cells and not in CD4(+) T cells. Telomerase, a ribonucleoprotein enzyme that can synthesize telomeric sequence onto chromosomal ends, can compensate for telomere loss. Here, we investigated if telomerase activity could explain differential telomere loss of CD4(+) and CD8(+) T cells in HIV-1 infection. Telomerase activity was higher in CD8(+) than in CD4(+) T cells from HIV-infected patients, but still in the same range as in healthy controls, and upregulation after stimulation was comparable to normal. Telomerase activity in lymph node CD4(+) and CD8(+) T cells from HIV-infected patients was in the same range as that in CD4(+) and CD8(+) T cells from peripheral blood (PB) and was normal in unseparated bone marrow cells. Thus, our study did not provide evidence for compartmentalized elongation of telomeres in HIV infection. In patients treated with reverse transcriptase inhibitors, telomerase activity was inhibited, but this did not lead to accelerated loss of telomere length in vivo. Thus, differential telomere loss in CD4(+) and CD8(+) T cells in HIV-1 infection cannot be explained by telomerase activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9920850

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Proliferation and telomere length in acutely mobilized blood mononuclear cells in HIV infected patients.

Authors:  S R Søndergaard; M V Essen; P Schjerling; H Ullum; B K Pedersen
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

2.  CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patients.

Authors:  Adrian F Ochsenbein; Stanley R Riddell; Michele Brown; Lawrence Corey; Gabriela M Baerlocher; Peter M Lansdorp; Philip D Greenberg
Journal:  J Exp Med       Date:  2004-12-06       Impact factor: 14.307

3.  Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation.

Authors:  C P Schröder; G B Wisman; S de Jong; W T van der Graaf; M H Ruiters; N H Mulder; L F de Leij; A G van der Zee; E G de Vries
Journal:  Br J Cancer       Date:  2001-05-18       Impact factor: 7.640

4.  No difference in the rate of change in telomere length or telomerase activity in HIV-infected patients after three years of darunavir/ritonavir with and without nucleoside analogues in the MONET trial.

Authors:  Ajantha Solomon; Surekha Tennakoon; Edwin Leeansyah; Jose Arribas; Andrew Hill; Yvon Van Delft; Christiane Moecklinghoff; Sharon R Lewin
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

5.  Apoptosis and telomeres shortening related to HIV-1 induced oxidative stress in an astrocytoma cell line.

Authors:  Michela Pollicita; Carolina Muscoli; Antonella Sgura; Alberto Biasin; Teresa Granato; Laura Masuelli; Vincenzo Mollace; Caterina Tanzarella; Claudio Del Duca; Paola Rodinò; Carlo Federico Perno; Stefano Aquaro
Journal:  BMC Neurosci       Date:  2009-05-22       Impact factor: 3.288

6.  Molecular mechanisms involved in the aging of the T-cell immune response.

Authors:  Marco Antonio Moro-García; Rebeca Alonso-Arias; Carlos López-Larrea
Journal:  Curr Genomics       Date:  2012-12       Impact factor: 2.236

7.  Accelerated biological ageing in HIV-infected individuals in South Africa: a case-control study.

Authors:  Sophia Pathai; Stephen D Lawn; Clare E Gilbert; Dagmara McGuinness; Liane McGlynn; Helen A Weiss; Jennifer Port; Theresa Christ; Karen Barclay; Robin Wood; Linda-Gail Bekker; Paul G Shiels
Journal:  AIDS       Date:  2013-09-24       Impact factor: 4.177

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.